Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Angiogenic targets for potential disorders.

Bhadada SV, Goyal BR, Patel MM.

Fundam Clin Pharmacol. 2011 Feb;25(1):29-47. doi: 10.1111/j.1472-8206.2010.00814.x. Review.

PMID:
20199582
2.

Angiogenesis: regulators and clinical applications.

Liekens S, De Clercq E, Neyts J.

Biochem Pharmacol. 2001 Feb 1;61(3):253-70. Review.

PMID:
11172729
3.

Diverse effects of statins on angiogenesis: new therapeutic avenues.

Elewa HF, El-Remessy AB, Somanath PR, Fagan SC.

Pharmacotherapy. 2010 Feb;30(2):169-76. doi: 10.1592/phco.30.2.169. Review.

PMID:
20099991
4.

[Neoplasms and angiogenesis].

Lewy-Trenda I.

Pol Merkur Lekarski. 2002 Sep;13(75):225-8. Review. Polish.

PMID:
12474576
5.

The pathophysiology of angiogenesis.

Polverini PJ.

Crit Rev Oral Biol Med. 1995;6(3):230-47. Review.

PMID:
8785263
6.

Angiogenesis--a new target for future therapy.

Pandya NM, Dhalla NS, Santani DD.

Vascul Pharmacol. 2006 May;44(5):265-74. Epub 2006 Mar 20. Review.

PMID:
16545987
7.

Editorial: Angiogenesis agents.

Marcinkiewicz C.

Curr Pharm Des. 2007;13(35):3543-4. No abstract available.

PMID:
18220790
8.

Angiogenesis: new insights and therapeutic potential.

Tomanek RJ, Schatteman GC.

Anat Rec. 2000 Jun 15;261(3):126-35. Review.

PMID:
10867630
9.

Therapeutic options to target angiogenesis in human malignancies.

Herbst RS.

Expert Opin Emerg Drugs. 2006 Nov;11(4):635-50. Review.

PMID:
17064223
10.

Development of new drugs in angiogenesis.

Ziche M, Donnini S, Morbidelli L.

Curr Drug Targets. 2004 Jul;5(5):485-93. Review.

PMID:
15216914
11.

Angiogenesis: molecular mechanisms of activation, promotion and maintenance.

Bikfalvi A.

J BUON. 2007 Sep;12 Suppl 1:S59-66. Review.

PMID:
17935279
12.

Cytokines and chemokines as regulators of angiogenesis in health and disease.

Benelli R, Lorusso G, Albini A, Noonan DM.

Curr Pharm Des. 2006;12(24):3101-15. Review.

PMID:
16918437
13.

[Angiogenesis and antiangiogenic cancer therapy].

Pour L, Hájek R, Buchler T, Maisnar V, Smolej L.

Vnitr Lek. 2004 Dec;50(12):930-8. Review. Czech.

PMID:
15717808
14.

Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.

Dell'Eva R, Pfeffer U, Indraccolo S, Albini A, Noonan D.

Endothelium. 2002;9(1):3-10. Review.

PMID:
12901356
15.
16.
17.

Angiotherapeutics from natural products: from bench to clinics?

Bernas G.

Clin Hemorheol Microcirc. 2003;29(3-4):199-203. Review.

PMID:
14724342
18.

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.

Kerbel RS, Viloria-Petit A, Klement G, Rak J.

Eur J Cancer. 2000 Jun;36(10):1248-57. Review.

PMID:
10882863
19.

[Angiogenesis and neoangiogenesis].

Savona C, Javerzat S, Perollet C, Bikfalvi A.

Rev Prat. 1997 Dec 15;47(20):2239-43. French.

PMID:
9616912
20.

Targets for regulating angiogenesis in the ageing endothelium.

Ballard VL, Edelberg JM.

Expert Opin Ther Targets. 2007 Nov;11(11):1385-99. Review.

PMID:
18028005

Supplemental Content

Support Center